Fecal Tests: From Blood to Molecular Markers (Q42027453)

15 October 2017

1 reference

title

Fecal Tests: From Blood to Molecular Markers (English)

1 reference

15 October 2017

0 references

Graeme P Young

1

1 reference

PMC publication ID

3029665

15 October 2017

Linda J W Bosch

series ordinal

2

1 reference

15 October 2017

18 January 2011

1 reference

Current colorectal cancer reports

15 October 2017

1 reference

15 October 2017

7

1 reference

15 October 2017

1

1 reference

15 October 2017

62-70

1 reference

Prostate cancer screening: current status and future perspectives.

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

MicroRNAs in colorectal cancer: translation of molecular biology into clinical application

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Membrane vesicles as conveyors of immune responses

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Which fecal occult blood test is best to screen for colorectal cancer?

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Stool DNA and occult blood testing for screen detection of colorectal neoplasia

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Genomic and epigenetic instability in colorectal cancer pathogenesis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Sensitivity and specificity of faecal tumour M2 pyruvate kinase for detection of colorectal adenomas in a large screening study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Comparative lesion sequencing provides insights into tumor evolution

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Comparing the DNA hypermethylome with gene mutations in human colorectal cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Comparative accuracy: assessing new tests against existing diagnostic pathways

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Stool screening for colorectal cancer: molecular approaches

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Phases of biomarker development for early detection of cancer

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Quantitative fluorescence determination of long-fragment DNA in stool as a marker for the early detection of colorectal cancer.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Detection of colorectal cancer cells from feces using quantitative real-time RT-PCR for colorectal cancer diagnosis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Sensitivity and specificity of a stool DNA multitarget assay panel for the detection of advanced colorectal neoplasia

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3029665

Oxysterol binding protein-related protein-5 is related to invasion and poor prognosis in pancreatic cancer

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11888-010-0084-8

The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11888-010-0084-8

A simplified, noninvasive stool DNA test for colorectal cancer detection

21 January 2018

1 reference

12 December 2020

Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps

1 reference

12 December 2020

Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability

1 reference

12 December 2020

Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening

1 reference

12 December 2020

Diagnostic precision of fecal calprotectin for inflammatory bowel disease and colorectal malignancy

1 reference

12 December 2020

DNA integrity as a potential marker for stool-based detection of colorectal cancer.

1 reference

12 December 2020

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population

1 reference

12 December 2020

Tumor pyruvate kinase isoenzyme type M2 and immunochemical fecal occult blood test: performance in screening for colorectal cancer

1 reference

12 December 2020

Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening

1 reference

12 December 2020

Map of differential transcript expression in the normal human large intestine

1 reference

12 December 2020

A new approach to fecal occult blood testing based on the detection of haptoglobin

1 reference

12 December 2020

Evaluation of new occult blood tests for detection of colorectal neoplasia

1 reference

12 December 2020

Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces

1 reference

12 December 2020

Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer

1 reference

12 December 2020

10.1007/S11888-010-0084-8

Identifiers

DOI

1 reference

15 October 2017

1 reference

PMC publication ID

3029665

15 October 2017

PubMed publication ID

21423316

1 reference

PMC publication ID

3029665